191 related articles for article (PubMed ID: 35892845)
1. Potential of Gold Nanoparticle in Current Radiotherapy Using a Co-Culture Model of Cancer Cells and Cancer Associated Fibroblast Cells.
Alhussan A; Palmerley N; Smazynski J; Karasinska J; Renouf DJ; Schaeffer DF; Beckham W; Alexander AS; Chithrani DB
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892845
[TBL] [Abstract][Full Text] [Related]
2. Gold nanoparticle mediated radiation response among key cell components of the tumour microenvironment for the advancement of cancer nanotechnology.
Bromma K; Cicon L; Beckham W; Chithrani DB
Sci Rep; 2020 Jul; 10(1):12096. PubMed ID: 32694592
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of Low Concentrations of Gold Nanoparticles: Complex Effects on Radiation Response and Fate of Cancer Cells.
Dobešová L; Gier T; Kopečná O; Pagáčová E; Vičar T; Bestvater F; Toufar J; Bačíková A; Kopel P; Fedr R; Hildenbrand G; Falková I; Falk M; Hausmann M
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057061
[No Abstract] [Full Text] [Related]
4. Utilizing Gold Nanoparticles as Prospective Radiosensitizers in 3D Radioresistant Pancreatic Co-Culture Model.
Alhussan A; Jackson N; Calisin R; Morgan J; Beckham W; Chithrani DB
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569898
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology Driven Cancer Chemoradiation: Exploiting the Full Potential of Radiotherapy with a Unique Combination of Gold Nanoparticles and Bleomycin.
Han O; Bromma K; Palmerley N; Bido AT; Monica M; Alhussan A; Howard PL; Brolo AG; Beckham W; Alexander AS; Chithrani DB
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213967
[TBL] [Abstract][Full Text] [Related]
6. Modeling gold nanoparticle radiosensitization using a clustering algorithm to quantitate DNA double-strand breaks with mixed-physics Monte Carlo simulation.
Liu R; Zhao T; Zhao X; Reynoso FJ
Med Phys; 2019 Nov; 46(11):5314-5325. PubMed ID: 31505039
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the fate of nanoparticles among key cell components of the tumor microenvironment for promoting cancer nanotechnology.
Bromma K; Bannister A; Kowalewski A; Cicon L; Chithrani DB
Cancer Nanotechnol; 2020; 11(1):8. PubMed ID: 32849921
[TBL] [Abstract][Full Text] [Related]
8. Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells.
Zhang Y; Elechalawar CK; Hossen MN; Francek ER; Dey A; Wilhelm S; Bhattacharya R; Mukherjee P
Bioact Mater; 2021 Feb; 6(2):326-332. PubMed ID: 32954051
[TBL] [Abstract][Full Text] [Related]
9. Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer.
Alhussan A; Jackson N; Eaton S; Santos ND; Barta I; Zaifman J; Chen S; Tam YYC; Krishnan S; Chithrani DB
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551622
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies.
Jain S; Coulter JA; Hounsell AR; Butterworth KT; McMahon SJ; Hyland WB; Muir MF; Dickson GR; Prise KM; Currell FJ; O'Sullivan JM; Hirst DG
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):531-9. PubMed ID: 21095075
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.
Zhang A; Qian Y; Ye Z; Chen H; Xie H; Zhou L; Shen Y; Zheng S
Cancer Med; 2017 Feb; 6(2):463-470. PubMed ID: 28097809
[TBL] [Abstract][Full Text] [Related]
12. FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer.
Zhang Z; Qin Y; Ji S; Xu W; Liu M; Hu Q; Ye Z; Fan G; Yu X; Liu W; Xu X
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):997-1008. PubMed ID: 34117747
[TBL] [Abstract][Full Text] [Related]
13. Impact of Cancer-Associated Fibroblast on the Radiation-Response of Solid Xenograft Tumors.
Steer A; Cordes N; Jendrossek V; Klein D
Front Mol Biosci; 2019; 6():70. PubMed ID: 31475157
[TBL] [Abstract][Full Text] [Related]
14. Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy.
Bannister AH; Bromma K; Sung W; Monica M; Cicon L; Howard P; Chow RL; Schuemann J; Chithrani DB
Br J Radiol; 2020 Feb; 93(1106):20190742. PubMed ID: 31778316
[TBL] [Abstract][Full Text] [Related]
15. Utilizing two-dimensional monolayer and three-dimensional spheroids to enhance radiotherapeutic potential by combining gold nanoparticles and docetaxel.
Bromma K; Beckham W; Chithrani DB
Cancer Nanotechnol; 2023; 14(1):80. PubMed ID: 37867929
[TBL] [Abstract][Full Text] [Related]
16. Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics.
Jackson N; Hill I; Alhussan A; Bromma K; Morgan J; Abousaida B; Zahra Y; Mackeyev Y; Beckham W; Herchko S; Krishnan S; Chithrani DB
Cancer Nanotechnol; 2023; 14(1):75. PubMed ID: 37781236
[TBL] [Abstract][Full Text] [Related]
17. The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts.
Ansems M; Span PN
Clin Transl Radiat Oncol; 2020 May; 22():90-97. PubMed ID: 32337377
[TBL] [Abstract][Full Text] [Related]
18. Quantification of gold nanoparticle photon radiosensitization from direct and indirect effects using a complete human genome single cell model based on Geant4.
Zhao X; Liu R; Zhao T; Reynoso FJ
Med Phys; 2021 Dec; 48(12):8127-8139. PubMed ID: 34738643
[TBL] [Abstract][Full Text] [Related]
19. Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response.
Jackson N; Alhussan A; Bromma K; Jay D; Donnelly JC; West FG; Lavasanifar A; Weinfeld M; Beckham W; Chithrani DB
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559288
[TBL] [Abstract][Full Text] [Related]
20. Octaarginine-modified gold nanoparticles enhance the radiosensitivity of human colorectal cancer cell line LS180 to megavoltage radiation.
Zhang X; Wang H; Coulter JA; Yang R
Int J Nanomedicine; 2018; 13():3541-3552. PubMed ID: 29950834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]